2010-2019年药材进口贸易情况及法规标准体系分析  

Chinese Medicinal Materials Import and Related Regulation and Standards in 2010-2019

作　　者：于志斌[1] 李得运 刘丽娜[2] 金红宇[2] YU Zhi-bin;LI De-yun;LIU Li-na;JIN Hong-yu(China Chamber of Commerce for Import&Export of Medicines&Health Products,Beijing 100010,China;National Institutes for Food and Drug Control,Beijing 100050,China)

机构地区：[1]中国医药保健品进出口商会,北京100010 [2]中国食品药品检定研究院,北京100050

出　　处：《中国现代中药》2022年第1期147-152,共6页Modern Chinese Medicine

摘　　要：作为世界上最大的传统医药市场,我国进口药材历史悠久、数量快速增长。对2010—2019年的药材进口情况进行回顾,系统梳理了当前进口药材的法规监管和标准体系,分析了当前存在的法规不协调、质量标准体系不完善等问题,建议通过监管创新和标准升级予以解决。As the world′s largest market of traditional medicine,China has a long history of importing Chinese medicinal materials due to the strong demand.This paper reviewed the import of Chinese medicinal materials in 2010-2019,systematically sorted out the current regulatory and standard system of imported Chinese medicinal materials,and discussed the existing problems,hoping to provide a useful reference for the reform and innovation of regulatory rules and standards in this industry.

关 键 词：中药材 进口 贸易 法规 中药材标准 

分 类 号：R288[医药卫生—中药学]